PVLA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Pieris Pharmaceuticals Inc (PVLA).


$15.84M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

PVLA Market Cap. (MRY)


PVLA Shares Outstanding (MRY)


PVLA Assets (MRY)


Total Assets

$88.23M

Total Liabilities

$25.63M

Total Investments

$0

PVLA Income (MRY)


Revenue

$0

Net Income

-$17.43M

Operating Expense

$14.10M

PVLA Cash Flow (MRY)


CF Operations

-$10.84M

CF Investing

$0

CF Financing

$87.09M

PVLA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PVLA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$88,234,000 (128.11%)

$38,680,000 (-59.49%)

$95,490,000 (-37.82%)

$153,560,000 (46.23%)

Assets Current

$88,234,000 (128.11%)

$38,680,000 (-47.32%)

$73,424,000 (-42.47%)

$127,625,000 (68.55%)

Assets Non-Current

$0 (0%)

$0 (0%)

$22,066,000 (-14.92%)

$25,935,000 (-11.45%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$62,607,000 (133.97%)

$26,758,000 (-4.19%)

$27,929,000 (-44.97%)

$50,755,000 (63.58%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$20,697,000 (-10.13%)

$23,031,000 (-11.35%)

Cash & Equivalents

$83,602,000 (380.58%)

$17,396,000 (-54.97%)

$38,635,000 (-67.19%)

$117,764,000 (67.19%)

Accumulated Other Comprehensive Income

$3,000 (-89.29%)

$28,000 (111.02%)

-$254,000 (-130.64%)

$829,000 (381.02%)

Deferred Revenue

$0 (0%)

$0 (0%)

$39,558,000 (-37.72%)

$63,519,000 (30.89%)

Total Investments

$0 (0%)

$8,970,000 (-56.32%)

$20,534,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$8,970,000 (-56.32%)

$20,534,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$358,000 (-87.65%)

$2,898,000 (-50.12%)

$5,810,000 (75.37%)

$3,313,000 (94.20%)

Trade & Non-Trade Payables

$4,586,000 (36.00%)

$3,372,000 (-18.83%)

$4,154,000 (-51.75%)

$8,609,000 (381.76%)

Accumulated Retained Earnings (Deficit)

-$93,735,000 (70.24%)

-$314,964,000 (-8.45%)

-$290,421,000 (-12.94%)

-$257,144,000 (-21.64%)

Tax Assets

$1,978,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$13,103,000 (-5.33%)

$13,841,000 (-13.12%)

Debt Current

$0 (0%)

$0 (0%)

$859,000 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$12,244,000 (-11.54%)

$13,841,000 (-13.12%)

Total Liabilities

$25,627,000 (114.96%)

$11,922,000 (-82.35%)

$67,561,000 (-34.28%)

$102,805,000 (38.96%)

Liabilities Current

$12,038,000 (0.97%)

$11,922,000 (-67.41%)

$36,583,000 (-27.65%)

$50,561,000 (128.32%)

Liabilities Non-Current

$13,589,000 (0%)

$0 (0%)

$30,978,000 (-40.71%)

$52,244,000 (0.78%)

PVLA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$42,810,000 (65.28%)

$25,902,000 (-17.56%)

$31,418,000 (7.14%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$5,944,000 (-64.73%)

$16,853,000 (2.80%)

$16,394,000 (-1.20%)

$16,593,000 (-0.72%)

Research & Development Expense

$8,151,000 (-80.50%)

$41,801,000 (-21.10%)

$52,982,000 (-20.51%)

$66,656,000 (43.25%)

Operating Expenses

$14,095,000 (-80.58%)

$72,566,000 (4.60%)

$69,376,000 (-16.66%)

$83,249,000 (31.63%)

Interest Expense

$4,317,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$17,434,000 (28.97%)

-$24,543,000 (26.25%)

-$33,277,000 (27.24%)

-$45,738,000 (-22.85%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$17,434,000 (28.97%)

-$24,543,000 (26.25%)

-$33,277,000 (27.24%)

-$45,738,000 (-22.85%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$17,434,000 (28.97%)

-$24,543,000 (26.25%)

-$33,277,000 (27.24%)

-$45,738,000 (-22.85%)

Weighted Average Shares

$2,225,934 (-97.53%)

$90,064,000 (21.43%)

$74,172,000 (14.91%)

$64,547,000 (18.48%)

Weighted Average Shares Diluted

$2,225,934 (-97.53%)

$90,064,000 (21.43%)

$74,172,000 (14.91%)

$64,547,000 (18.48%)

Earning Before Interest & Taxes (EBIT)

-$13,117,000 (46.56%)

-$24,543,000 (26.25%)

-$33,277,000 (27.24%)

-$45,738,000 (-23.40%)

Gross Profit

$0 (0%)

$42,810,000 (65.28%)

$25,902,000 (-17.56%)

$31,418,000 (7.14%)

Operating Income

-$14,095,000 (52.63%)

-$29,756,000 (31.55%)

-$43,474,000 (16.12%)

-$51,831,000 (-52.80%)

PVLA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$12,002,000 (156.52%)

-$21,236,000 (-2137.72%)

-$949,000 (-102.42%)

Net Cash Flow from Financing

$87,089,000 (339.95%)

$19,795,000 (174.40%)

$7,214,000 (-87.80%)

$59,127,000 (484.55%)

Net Cash Flow from Operations

-$10,840,000 (79.86%)

-$53,819,000 (10.20%)

-$59,932,000 (-682.40%)

-$7,660,000 (83.31%)

Net Cash Flow / Change in Cash & Cash Equivalents

$76,252,000 (459.02%)

-$21,239,000 (73.16%)

-$79,129,000 (-267.19%)

$47,328,000 (478.86%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$12,173,000 (160.28%)

-$20,195,000 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$171,000 (83.57%)

-$1,041,000 (-9.69%)

-$949,000 (65.19%)

Issuance (Repayment) of Debt Securities

$18,304,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$57,459,000 (190.27%)

$19,795,000 (174.40%)

$7,214,000 (-87.80%)

$59,127,000 (484.55%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$3,000 (-99.62%)

$783,000 (115.13%)

-$5,175,000 (-62.23%)

-$3,190,000 (-167.23%)

Share Based Compensation

$830,000 (-75.22%)

$3,349,000 (-23.92%)

$4,402,000 (-15.59%)

$5,215,000 (2.46%)

Depreciation Amortization & Accretion

$0 (0%)

$1,781,000 (-35.94%)

$2,780,000 (17.40%)

$2,368,000 (11.33%)

PVLA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-57.30% (55.41%)

-128.50% (11.74%)

-145.60% (-14.65%)

EBITDA Margin

-

-53.20% (54.80%)

-117.70% (14.71%)

-138.00% (-15.77%)

Return on Average Equity (ROAE)

-58.30% (32.76%)

-86.70% (-5.22%)

-82.40% (14.61%)

-96.50% (-10.92%)

Return on Average Assets (ROAA)

-42.70% (-16.35%)

-36.70% (-23.15%)

-29.80% (4.18%)

-31.10% (3.42%)

Return on Sales (ROS)

-

-57.30% (55.41%)

-128.50% (11.74%)

-145.60% (-15.19%)

Return on Invested Capital (ROIC)

606.80% (416.87%)

-191.50% (-81.34%)

-105.60% (74.85%)

-419.80% (-505.77%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.53 (-127.45%)

-0.67 (70.84%)

-2.31 (56.59%)

-5.32 (-44.83%)

Price to Sales Ratio (P/S)

-

0.38 (-87.14%)

2.98 (-61.65%)

7.77 (67.19%)

Price to Book Ratio (P/B)

0.25 (-62.35%)

0.67 (-75.75%)

2.77 (-48.37%)

5.37 (19.00%)

Debt to Equity Ratio (D/E)

0.41 (-8.30%)

0.45 (-81.56%)

2.42 (19.40%)

2.03 (-15.02%)

Earnings Per Share (EPS)

-7.83 (-2800.00%)

-0.27 (40.00%)

-0.45 (36.62%)

-0.71 (-4.41%)

Sales Per Share (SPS)

0 (0%)

0.47 (36.10%)

0.35 (-28.34%)

0.49 (-9.48%)

Free Cash Flow Per Share (FCFPS)

-4.87 (-713.02%)

-0.6 (27.13%)

-0.82 (-518.05%)

-0.13 (85.09%)

Book Value Per Share (BVPS)

28.13 (9370.03%)

0.3 (-21.22%)

0.38 (-52.04%)

0.79 (37.89%)

Tangible Assets Book Value Per Share (TABVPS)

39.64 (9139.86%)

0.43 (-66.67%)

1.29 (-45.90%)

2.38 (23.46%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (75.00%)

-4 (-100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.27 (133.04%)

0.12 (108.69%)

-1.32 (64.53%)

-3.73 (-47.31%)

Asset Turnover

0 (0%)

0.64 (175.43%)

0.23 (8.41%)

0.21 (-15.75%)

Current Ratio

7.33 (125.96%)

3.24 (61.63%)

2.01 (-20.48%)

2.52 (-26.18%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$10,840,000 (79.92%)

-$53,990,000 (11.45%)

-$60,973,000 (-608.25%)

-$8,609,000 (82.29%)

Enterprise Value (EV)

-$3,520,120 (-34.82%)

-$2,610,949 (-106.47%)

$40,350,503 (-75.06%)

$161,788,014 (82.89%)

Earnings Before Tax (EBT)

-$17,434,000 (28.97%)

-$24,543,000 (26.25%)

-$33,277,000 (27.24%)

-$45,738,000 (-23.40%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$13,117,000 (42.37%)

-$22,762,000 (25.36%)

-$30,497,000 (29.68%)

-$43,370,000 (-24.13%)

Invested Capital

-$7,406,000 (-179.11%)

$9,362,000 (-71.95%)

$33,375,000 (3712.01%)

-$924,000 (-103.26%)

Working Capital

$76,196,000 (184.76%)

$26,758,000 (-27.37%)

$36,841,000 (-52.19%)

$77,064,000 (43.84%)

Tangible Asset Value

$88,234,000 (128.11%)

$38,680,000 (-59.49%)

$95,490,000 (-37.82%)

$153,560,000 (46.23%)

Market Capitalization

$15,842,880 (-11.94%)

$17,991,051 (-76.75%)

$77,382,503 (-71.59%)

$272,395,014 (94.67%)

Average Equity

$29,886,000 (5.58%)

$28,306,000 (-29.90%)

$40,377,750 (-14.80%)

$47,391,250 (10.73%)

Average Assets

$40,826,000 (-39.03%)

$66,964,500 (-39.95%)

$111,519,250 (-24.21%)

$147,140,000 (27.31%)

Invested Capital Average

-$2,161,750 (-116.87%)

$12,816,000 (-59.34%)

$31,520,500 (189.32%)

$10,894,500 (-79.63%)

Shares

1,320,240 (-98.66%)

98,851,927 (32.85%)

74,406,253 (3.25%)

72,062,173 (28.75%)